Adamis Pharma's market cap is currently ―. The company's EPS TTM is $-0.176; its P/E ratio is -0.68; Adamis Pharma is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 2.15M	$ 1.51M	$ 39.85K	$ 1.15M	$ -1.16M
Gross Profit	$ -331.11K	$ -141.90K	$ -649.33K	$ -309.07K	$ -3.15M
EBIT	$ -2.64M	$ -4.27M	$ -8.34M	$ -10.19M	$ -7.81M
EBITDA	$ -2.27M	$ -3.87M	$ -7.97M	$ -9.85M	$ -7.45M
Net Income Common Stockholders	$ -3.33M	$ -4.40M	$ -8.40M	$ -10.35M	$ -8.77M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.08M	$ 2.42M	$ 8.88M	$ 17.77M	$ 23.22M
Total Assets	$ 10.93M	$ 12.14M	$ 17.69M	$ 30.55M	$ 38.30M
Total Debt	$ 342.56K	$ 432.02K	$ 519.68K	$ 2.46M	$ 692.43K
Net Debt	$ -738.80K	$ -1.99M	$ -8.36M	$ -15.31M	$ -22.53M
Total Liabilities	$ 11.74M	$ 9.29M	$ 10.65M	$ 14.65M	$ 12.42M
Stockholders Equity	$ -808.07K	$ 2.85M	$ 7.04M	$ 15.90M	$ 25.88M
Cash Flow	-
Free Cash Flow	$ -1.61M	$ -7.71M	$ -10.25M	$ -7.01M	$ -6.90M
Operating Cash Flow	$ -1.52M	$ -7.50M	$ -9.89M	$ -6.99M	$ -6.67M
Investing Cash Flow	$ 155.30K	$ 779.22K	$ 1.02M	$ 1.53M	$ 1.17M
Financing Cash Flow	$ 0.00	$ 285.00K	$ 0.00	$ 0.00	$ -42.85K

Currency in USD

Adamis Pharma Earnings and Revenue History

Income Statement >

Adamis Pharma Debt to Assets

Balance Sheet >

Adamis Pharma Cash Flow

Cash Flow >

Adamis Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing